Literature DB >> 8990136

Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases.

M B Amin1, T B Crotty, S K Tickoo, G M Farrow.   

Abstract

Renal oncocytoma has several features that overlap with other renal neoplasms with a preponderance of granular cytoplasm, such as chromophobe, granular, and papillary renal cell carcinomas. Lack of knowledge of this entire spectrum of eosinophilic renal cell neoplasms has led to several misconceptions in the literature regarding renal oncocytoma. These include the "grading of oncocytomas," "metastatic oncocytomas," and the impression that renal oncocytoma is usually low grade and lacks prominent nucleoli. In order to further characterize the histologic features and embelLish diagnostic criteria, we evaluated 93 tumors from 80 patients. Four tumors were bilateral and two were multifocal. The mean age was 67.2 years (32-89 years), men were more commonly affected (3.1:1), and 82.7% tumors were incidental findings. Grossly, the tumors were mahogany brown, lacked necrosis, and averaged 4.4 cm in size (range 0.6-15 cm). Histologically, renal oncocytoma was composed of an exclusive or predominant component of acidophilic cells with three architectural patterns of disposition: (a) The "classic" pattern (57.5%), composed of a characteristic nested or organoid arrangement of cells, each surrounded by a distinct reticulin framework; (b) a "tubulocystic pattern" (6.3%) with numerous closely packed cystically dilated tubular structures; and (c) "mixed pattern" (36.2%), which had both the organoid and tubulocystic patterns. A gross or microscopic scar was noted in 53.8% cases, and histologically a distinctive myxoid and/or hyalinized stroma separated nests of cells. Generally, the nuclei of renal oncocytoma were round with uniform nuclear contours. Nearly half of the tumors had prominent nucleoli (42.5% had prominent nucleoli equivalent to Fuhrman's grade III or IV). Pleomorphism was absent in 50% of cases but was conspicuous in 12.5% of cases including foci of bizarre cells. Other atypical features included perinephric fat involvement (11.3%), renal parenchymal invasion not associated with desmoplasia (10%), and hemorrhage (31.3%). Renal oncocytoma by definition lacks areas of clear cell carcinoma, significant lesional necrosis, or conspicuous papillary formations. Ancillary features noted included normal-appearing renal tubules within the lesion (15%), intranuclear holes (20%), psammoma bodies (7.5%), and foam cells (7.5%). 15% of tumors were locally excised, and 85% resulted in radical nephrectomy. Mean follow-up of 7.6 years (range 15-200 months) showed no evidence of recurrence, metastasis, or death due to tumor. In conclusion, renal oncocytoma, herein described, is a benign neoplasm and therefore does not merit a nuclear grading scheme. It has unique histologic features including an organoid and tubulocystic architecture, myxoid or hyalinized stroma, and occasionally some atypical findings including nuclear pleomorphism, prominent nucleoli, and adjacent renal parenchymal and perinephric fat involvement.

Entities:  

Mesh:

Year:  1997        PMID: 8990136     DOI: 10.1097/00000478-199701000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  57 in total

1.  Renal oncocytoma with a novel chromosomal rearrangement, der(13)t(13;16)(p11;p11), associated with a renal cell carcinoma.

Authors:  X Leroy; E Leteurtre; P H Mahe; B Gosselin; B Delobel; M F Croquette
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  Multiple Synchronous Tumors in a Patient: A Rare Entity.

Authors:  Panteleimon Tsipas; Georgios Laoutides; Athanassios Archontakis; Dimitrios Sampaziotis; Christophoros Kotoulas
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Yan Zhong; Haiyi Wang; Yanguang Shen; Aitao Guo; Jia Wang; Suhai Kang; Lu Ma; Jingjing Pan; Huiyi Ye
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

Review 4.  Radiologic-pathologic correlations of intratumoral tissue components in the most common solid and cystic renal tumors. Pictorial review.

Authors:  Emilio Quaia; Rossana Bussani; Maria Cova; Roberto Pozzi Mucelli
Journal:  Eur Radiol       Date:  2005-03-08       Impact factor: 5.315

5.  Small-cell variant of renal oncocytoma with dominating solid growth pattern: a potential diagnostic pitfall.

Authors:  Gaetano Magro; Marina Paola Gardiman; Maria Rosa Lopes; Michal Michal
Journal:  Virchows Arch       Date:  2005-11-16       Impact factor: 4.064

6.  Multilocular cystic renal oncocytoma.

Authors:  X Leroy; S Aubert; L Lemaitre; J Haffner; J Biserte; B Gosselin
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

7.  Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.

Authors:  Jay Amin; Bo Xu; Shervin Badkhshan; Terrance T Creighton; Daniel Abbotoy; Christine Murekeyisoni; Kristopher M Attwood; Thomas Schwaab; Craig Hendler; Michael Petroziello; Charles L Roche; Eric C Kauffman
Journal:  Clin Cancer Res       Date:  2018-05-11       Impact factor: 12.531

8.  Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation--a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases.

Authors:  O Hes; T Vanecek; D M Perez-Montiel; I Alvarado Cabrero; M Hora; S Suster; J Lamovec; R Curik; V Mandys; M Michal
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

Review 9.  Association of angiomyolipoma and oncocytoma of the kidney: a case report and review of the literature.

Authors:  K Pillay; J Lazarus; H C Wainwright
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

Review 10.  Update on oncocytoma.

Authors:  Stephen M Schatz; Michael M Lieber
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.